Results 261 to 270 of about 6,129,049 (301)
Some of the next articles are maybe not open access.
Immunotherapy of Invasive Fungal Disease
2017Despite the availability of new antifungal compounds, morbidity and mortality of invasive fungal disease are still unacceptably high, in particular in immunocompromised patients such as patients with hematological malignancies, allogeneic hematopoietic stem cell, solid organ transplant recipients, or advanced HIV infection.
Thomas Lehrnbecher +1 more
openaire +1 more source
Diagnosis of invasive fungal diseases in pediatric patients
Expert Review of Anti-infective Therapy, 2016The optimal management of invasive fungal infections (IFIs) in children requires prompt and precise diagnosis that enables timely implementation of appropriate antifungal therapy and decreased use of unnecessary toxic antifungals. Areas covered: Traditional approaches such as culture, microscopy and histopathology remain the gold standard but are often
Zoi-Dorothea, Pana +2 more
openaire +2 more sources
Diagnosis of Invasive Fungal Disease
2011The diagnosis of invasive fungal infections (IFI) relies on the critical assessment of clinical presentation, associated risk factors, and careful interpretation of the appropriate diagnostic tests. Frequently, clinicians have to initiate antifungal therapy based on their clinical suspicion and without having made a definitive diagnosis, particularly ...
Dionissios Neofytos, Kieren Marr
openaire +1 more source
Challenges in Invasive Fungal Disease
2019The term invasive fungal disease (IFD) incorporates severe systemic or deep-seated infections due to fungi. A rise in the prevalence of IFD has been observed in recent years, primarily due to the rising numbers of susceptible host population, increasing invasive therapeutic interventions and immunosuppressive treatments.
Arunaloke Chakrabarti, Shreya Singh
openaire +1 more source
Posaconazole for treatment of refractory invasive fungal disease
Mycoses, 2006SummaryInvasive fungal infections are usually associated with immunocompromised states About 40–60% of these patients are refractory to standard antifungal therapy We describe the effect of posoconazole in the treatment of a 12 years‐old girl with uncontrolled diabetes mellitus with life‐threatening cerebral mucor mycosis and a 4 year old girl boy with
G. Notheis +10 more
openaire +3 more sources
Modeling of the Invasion of a Fungal Disease over a Vineyard
2007The spatiotemporal spreading of a fungal disease over a vineyard is investigated using a SEIR-type model coupled with a set of partial differential equations describing the dispersal of the spores. The model takes into account both short and long range dispersal of spores and growth of foliar surface. Results of numerical simulations are presented.
Burie, J-B. +2 more
openaire +3 more sources
Surgery for pediatric invasive fungal sinonasal disease
The Laryngoscope, 2013Objectives/HypothesisTo evaluate the management and outcomes of children with invasive fungal sinonasal disease treated with radical surgery.Study DesignRetrospective case series.MethodsFrom 1994 to 2007, 11 pediatric patients were identified with invasive fungal sinonasal disease treated surgically by the same pediatric otolaryngologist.
Farhad, Ardeshirpour +5 more
openaire +2 more sources
[General epidemiology of invasive fungal disease].
Enfermedades infecciosas y microbiologia clinica, 2012Invasive mycoses associated with high morbidity and mortality rates are increasing among immunocompromised or severely ill patients. Candida, Cryptococcus, Pneumocystis and Aspergillus are most prevalent agents with varying distribution as regards geography, patient condition and hospital units.
Peman, Javier, Salavert, Miguel
openaire +2 more sources
Invasive fungal diseases in patients with rheumatic diseases
2020Invasive fungal diseases (IFDs), especially pneumocystosis, cryptococcosis, histoplasmosis, and coccidioidomycosis, are increasingly observed among patients with systemic autoimmune diseases. Such patients are susceptible to the abovementioned IFDs because of their disease-related immunological defects and/or concomitant immunosuppressive therapies ...
Antinori S., Giacomelli A.
openaire +1 more source
Galactomannan in the bronchoalveolar lavage for diagnosing invasive fungal disease
European Respiratory Journal, 2014Invasive fungal disease (IFD) is a significant cause of morbidity and mortality in immunocompromised patients. We hypothesize that galactomannan, a component of fungal cell wall, as measured in the bronchoalveolar lavage (BAL GM) might be a diagnostic adjunct in hematological malignancies.
Affolter, Kristina +6 more
openaire +3 more sources

